uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Apremilast Viatris
Application withdrawn
Human
Details
EMA number
EMEA/H/C/006193
ATC code
L04AA32
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of psoriatic arthritis, psoriasis, Behçet’s disease.
MeSH:
Arthritis, Psoriatic;Psoriasis;Behcet Syndrome
Group:
Immunosuppressants
Active substances
apremilast
Marketing Authorisation Holder
Viatris Limited
MAH
Apremilast Viatris | uMedical